89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
8.76
+0.38 (4.53%)
Nov 22, 2024, 4:00 PM EST - Market closed
89bio Market Cap
89bio has a market cap or net worth of $1.03 billion as of November 22, 2024. Its market cap has increased by 64.61% in one year.
Market Cap
1.03B
Enterprise Value
643.81M
1-Year Change
64.61%
Ranking
Category
Stock Price
$8.76
Market Cap Chart
Since November 12, 2019, 89bio's market cap has increased from $256.62M to $1.03B, an increase of 301.38%. That is a compound annual growth rate of 31.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 939.48M | -9.76% |
| Dec 29, 2023 | 1.04B | 75.74% |
| Dec 30, 2022 | 592.42M | 123.48% |
| Dec 31, 2021 | 265.09M | -45.28% |
| Dec 31, 2020 | 484.45M | 33.64% |
| Dec 31, 2019 | 362.51M | 41.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.07B |
| The Pennant Group | 1.06B |
| Gyre Therapeutics | 1.01B |
| Cogent Biosciences | 1.01B |
| Pulse Biosciences | 995.34M |
| AMN Healthcare Services | 987.06M |
| Vir Biotechnology | 983.31M |
| Weave Communications | 982.41M |